Are multiple sclerosis therapies safe in severe acute respiratory syndrome coronavirus 2 times ?
Francesco Ferrara, Raffaele La Porta, Priscilla Santilli, Vilma D'Aiuto, Antonio VitielloIndian Journal of Pharmacology 2020 52(5):441-442
Source: Indian Journal of Pharmacology - Category: Drugs & Pharmacology Authors: Francesco Ferrara Raffaele La Porta Priscilla Santilli Vilma D & #39;Aiuto Antonio Vitiello Source Type: research
More News: Coronavirus | COVID-19 | Drugs & Pharmacology | India Health | Multiple Sclerosis | Respiratory Medicine | SARS